Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02064244 · ClinicalTrials.gov registry record
Inferior Vena Cava (IVC) Size in Acute Renal Failure
A clinical trial, sponsored by University of Oklahoma.
- Completed
- Registry status
- 33
- Enrollment target
NCT02064244: Completed study, sponsored by University of Oklahoma.
NCT02064244 is a clinical trial that has completed, run by University of Oklahoma. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02064244 has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
Bedside ultrasonographic assessment of IVC size and IVC collapsibility index can be used to guide the management of patients with acute kidney injury with and without volume overload in the intensive care unit
Primary Outcome
percentage of patients with improved Creatinine level in group 1 and 2
Interventions
- OTHER Ultrasound for measurement of Inferior Vena Cava size.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-05 |
What the finished NCT02064244 record still lists
NCT02064244 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound for measurement of Inferior Vena Cava size. is the first listed.
NCT02064244 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02064244 about?
NCT02064244 is a clinical study titled "Inferior Vena Cava (IVC) Size in Acute Renal Failure". Bedside ultrasonographic assessment of IVC size and IVC collapsibility index can be used to guide the management of patients with acute kidney injury with and without volume overload in the intensive care unit
What is the current status of trial NCT02064244?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2014-02. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02064244?
The interventions under investigation include: Ultrasound for measurement of Inferior Vena Cava size. (OTHER).
Who is sponsoring clinical trial NCT02064244?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia